233 related articles for article (PubMed ID: 37795100)
1. Expanded Hemodialysis ameliorates uremia-induced impairment of vasculoprotective KLF2 and concomitant proinflammatory priming of endothelial cells through an ERK/AP1/cFOS-dependent mechanism.
Zhao H; Wu D; Gyamfi MA; Wang P; Luecht C; Pfefferkorn AM; Ashraf MI; Kamhieh-Milz J; Witowski J; Dragun D; Budde K; Schindler R; Zickler D; Moll G; Catar R
Front Immunol; 2023; 14():1209464. PubMed ID: 37795100
[TBL] [Abstract][Full Text] [Related]
2. Expanded Hemodialysis Therapy Ameliorates Uremia-Induced Systemic Microinflammation and Endothelial Dysfunction by Modulating VEGF, TNF-α and AP-1 Signaling.
Catar R; Moll G; Kamhieh-Milz J; Luecht C; Chen L; Zhao H; Ernst L; Willy K; Girndt M; Fiedler R; Witowski J; Morawietz H; Ringdén O; Dragun D; Eckardt KU; Schindler R; Zickler D
Front Immunol; 2021; 12():774052. PubMed ID: 34858433
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Circulating Levels of Uremic Toxins in Hemodialysis Patients Treated with Medium Cut-Off Membranes and High-Flux Membranes: Theranova in Sisli Hamidiye Etfal (THE SHE) Randomized Control Study.
Sevinc M; Hasbal NB; Yilmaz V; Basturk T; Ahbap E; Sakaci T; Ozcafer PN; Unsal A
Blood Purif; 2020; 49(6):733-742. PubMed ID: 32634815
[TBL] [Abstract][Full Text] [Related]
4. Uremic Advanced Glycation End Products and Protein-Bound Solutes Induce Endothelial Dysfunction Through Suppression of Krüppel-Like Factor 2.
Saum K; Campos B; Celdran-Bonafonte D; Nayak L; Sangwung P; Thakar C; Roy-Chaudhury P; Owens AP
J Am Heart Assoc; 2018 Jan; 7(1):. PubMed ID: 29301761
[TBL] [Abstract][Full Text] [Related]
5. The Evolving Patterns of Uremia: Unmet Clinical Needs in Dialysis.
Yu X
Contrib Nephrol; 2017; 191():1-7. PubMed ID: 28910786
[TBL] [Abstract][Full Text] [Related]
6. Medium Cut-Off (MCO) Membranes Reduce Inflammation in Chronic Dialysis Patients-A Randomized Controlled Clinical Trial.
Zickler D; Schindler R; Willy K; Martus P; Pawlak M; Storr M; Hulko M; Boehler T; Glomb MA; Liehr K; Henning C; Templin M; Trojanowicz B; Ulrich C; Werner K; Fiedler R; Girndt M
PLoS One; 2017; 12(1):e0169024. PubMed ID: 28085888
[TBL] [Abstract][Full Text] [Related]
7. Inflammation and Protein-Energy Wasting in the Uremic Milieu.
Jankowska M; Cobo G; Lindholm B; Stenvinkel P
Contrib Nephrol; 2017; 191():58-71. PubMed ID: 28910791
[TBL] [Abstract][Full Text] [Related]
8. Contribution of high flux membranes to the therapy of uremia-associated dyslipidemia.
Azak A; Huddam B; Öneç K; Koçak G; Dede F; Aylı D; Duranay M
Ther Apher Dial; 2012 Dec; 16(6):595-9. PubMed ID: 23190521
[TBL] [Abstract][Full Text] [Related]
9. In Vitro Dialysis of Cytokine-Rich Plasma With High and Medium Cut-Off Membranes Reduces Its Procalcific Activity.
Willy K; Hulko M; Storr M; Speidel R; Gauss J; Schindler R; Zickler D
Artif Organs; 2017 Sep; 41(9):803-809. PubMed ID: 28524237
[TBL] [Abstract][Full Text] [Related]
10. Performance of hemodialysis with novel medium cut-off dialyzers.
Kirsch AH; Lyko R; Nilsson LG; Beck W; Amdahl M; Lechner P; Schneider A; Wanner C; Rosenkranz AR; Krieter DH
Nephrol Dial Transplant; 2017 Jan; 32(1):165-172. PubMed ID: 27587605
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of medium cut-off dialyzers and comparison with high-flux dialyzers in patients on maintenance hemodialysis: A systematic review and meta-analysis.
Yang J; Ke G; Liao Y; Guo Y; Gao X
Ther Apher Dial; 2022 Aug; 26(4):756-768. PubMed ID: 34773675
[TBL] [Abstract][Full Text] [Related]
12. Effects of Expanded Hemodialysis Therapy on Clinical Outcomes.
Mitra S; Kharbanda K
Contrib Nephrol; 2017; 191():188-199. PubMed ID: 28910802
[TBL] [Abstract][Full Text] [Related]
13. Effects of Hemodialysis Therapy Using Dialyzers with Medium Cut-Off Membranes on Middle Molecules.
Kirsch AH; Rosenkranz AR; Lyko R; Krieter DH
Contrib Nephrol; 2017; 191():158-167. PubMed ID: 28910799
[TBL] [Abstract][Full Text] [Related]
14. Uremic serum inhibits in vitro expression of chemokine SDF-1: impact of uremic toxicity on endothelial injury.
Ribeiro V; Bosquetti B; Gonçalves SM; Bucharles SG; Rempel L; Maciel RA; de Oliveira RB; Pecoits-Filho R; Stinghen AE
J Bras Nefrol; 2014; 36(2):123-31. PubMed ID: 25055351
[TBL] [Abstract][Full Text] [Related]
15. Uremic Serum Induces Inflammation in Cultured Human Endothelial Cells and Triggers Vascular Repair Mechanisms.
Eloueyk A; Osta B; Alameldinne R; Awad D
Inflammation; 2019 Dec; 42(6):2003-2010. PubMed ID: 31312972
[TBL] [Abstract][Full Text] [Related]
16. Experimental Lung Injury Reduces Krüppel-like Factor 2 to Increase Endothelial Permeability via Regulation of RAPGEF3-Rac1 Signaling.
Huang RT; Wu D; Meliton A; Oh MJ; Krause M; Lloyd JA; Nigdelioglu R; Hamanaka RB; Jain MK; Birukova A; Kress JP; Birukov KG; Mutlu GM; Fang Y
Am J Respir Crit Care Med; 2017 Mar; 195(5):639-651. PubMed ID: 27855271
[TBL] [Abstract][Full Text] [Related]
17. Hemodialysis removes uremic toxins that alter the biological actions of endothelial cells.
Zafeiropoulou K; Bita T; Polykratis A; Karabina S; Vlachojannis J; Katsoris P
PLoS One; 2012; 7(2):e30975. PubMed ID: 22383985
[TBL] [Abstract][Full Text] [Related]
18. Imbalance of Th22/Treg cells causes microinflammation in uremic patients undergoing hemodialysis.
Ren T; Xiong J; Liu G; Wang S; Tan Z; Fu B; Zhang R; Liao X; Wang Q; Guo Z
Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31427482
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase 5 interacts with Krüppel-like factor 2 and inhibits its transcriptional activity in endothelium.
Kwon IS; Wang W; Xu S; Jin ZG
Cardiovasc Res; 2014 Oct; 104(1):127-37. PubMed ID: 25096223
[TBL] [Abstract][Full Text] [Related]
20. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
